Dexrazoxane Intravenous and Rifadin IV Intravenous
Determining the interaction of Dexrazoxane Intravenous and Rifadin IV Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: rifampin
Brand name: Rifadin IV, Rifadin, Rimactane
Synonyms: Rifadin IV (Intravenous), Rifadin IV
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Rifamate
- Dexrazoxane Intravenous-Rifampin
- Dexrazoxane Intravenous-Rifampin and Isoniazid
- Dexrazoxane Intravenous-Rifampin Capsules
- Dexrazoxane Intravenous-Rifampin Injection
- Dexrazoxane Intravenous-Rifampin Intravenous
- Rifadin IV Intravenous-Dextenza Insert
- Rifadin IV Intravenous-Dextenza intraocular
- Rifadin IV Intravenous-Dextran 40
- Rifadin IV Intravenous-Dextran 70 6% in 5% Dextrose high molecular weight
- Rifadin IV Intravenous-Dextran 75
- Rifadin IV Intravenous-Dextran high molecular weight